SecBot SecBot
PRESS-RELEASE ·Filed Mar 5, 2026

QIPT

Quipt Home Medical Corp.
NEUTRAL
Impact 9/10
Horizondays Processed7mo ago WireGlobeNewswire
Press release · M&A
Actionable Insight • Neutral

Traders should expect QIPT shares to converge toward the $3.65 offer price, with minimal upside unless a competing bid emerges. Post-closing, the stock will no longer trade publicly. Arbitrage opportunity exists only if closing risks remain, but final court approval reduces execution risk significantly.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d
QIPT ▲ +0.27% at T+5d
NEUTRAL call +0.27% · α vs SPY +1.80% · entry $3.64 → $3.65
Next anchor: T+20d due 7mo ago
Entry = T+0 close
Mar 5, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.85%
$3.64
settled 8mo ago
T+5d
+0.27%
call +0.27% · α +1.80%
$3.65
settled 8mo ago
T+20d
Pending
due 7mo ago
T+60d
Pending
due 5mo ago

Price Chart

Loading chart...

Executive Summary

Quipt Home Medical Corp. (QIPT) is being acquired by affiliates of Kingswood Capital Management and Forager Capital Management for $3.65 per share in cash. The deal, which received final court approval, is expected to close by March 16, 2026, after which QIPT will be delisted from both the TSX and Nasdaq and cease to be a public company.

Key Financial Metrics

Deal Value
$161.0M

Key Facts

  • Acquisition price is $3.65 per share in cash
  • Final court approval obtained from Supreme Court of British Columbia
  • Expected closing date is March 16, 2026
  • Shares will be delisted from TSX and Nasdaq post-closing
  • Company will cease to be a reporting issuer in Canada and the U.S.
  • Acquirers are affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC

Financial Impact

Total deal value not disclosed, but implied equity value is approximately $161 million based on current market cap

marketCapdilutionliquidity

Risk Factors

  • Failure to satisfy remaining closing conditions (regulatory or third-party approvals)
  • Potential delays beyond March 16, 2026
  • Risk of deal termination if conditions are not met

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3250784
3 reports for QIPT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for QIPT — sortable, filterable
TypeNow
Mar 26, 2026
30w ago
15-12G
BEARISH ★ 7/10
$3.65 $3.65· 0.00%▼ −1.68%—
Mar 16, 2026
32w ago
Press Release
NEUTRAL ★ 9/10
$3.65 $3.65· 0.00%▼ −0.27%—
Mar 5, 2026
33w ago
Press Release
NEUTRAL ★ 9/10
$3.64 $3.64· 0.00%▼ −0.85%—
Showing 3 of 3

US Market Status

Market Closed — Opens in 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 5, 2026